These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 6796530)

  • 1. Production of T-cell lines with inhibitory or stimulatory activity against syngeneic tumors in vivo. A preliminary report.
    Mulé JJ; Forstrom JW; George E; Hellström I; Hellström KE
    Int J Cancer; 1981 Nov; 28(5):611-4. PubMed ID: 6796530
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cell-mediated suppression of tumor immunity has a non-specific component. I. Evidence from transplantation tests.
    Hellström KE; Hellström I
    Int J Cancer; 1981; 27(4):481-5. PubMed ID: 6168591
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A critical role for natural killer T cells in immunosurveillance of methylcholanthrene-induced sarcomas.
    Crowe NY; Smyth MJ; Godfrey DI
    J Exp Med; 2002 Jul; 196(1):119-27. PubMed ID: 12093876
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phenotypes associated with tumor rejection mediated by cyclophosphamide and syngeneic tumor-sensitized T lymphocytes: potential mechanisms of action.
    Evans R
    Int J Cancer; 1984 Mar; 33(3):381-8. PubMed ID: 6607893
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cell-mediated reactivity to antigens shared by Moloney-virus-induced lymphomas (LSTRA) and certain 3-methylcholanthrene-induced mouse sarcomas.
    Hellström I; Hellström KE; Zeidman L; Bernstein ID; Brown JP
    Int J Cancer; 1979 Apr; 23(4):555-64. PubMed ID: 86527
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cross-reacting tumor associated transplantation antigen on primary 3-methylcholanthrene-induced BALB/c sarcomas.
    Coggin JH
    Mol Biother; 1989; 1(4):223-8. PubMed ID: 2818874
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of IL-1 molecules on growth patterns of 3-MCA-induced cell lines: an interplay between immunogenicity and invasive potential.
    Voronov E; Reich E; Dotan S; Dransh P; Cohen I; Huszar M; Fogel M; Kleinman HK; White RM; Apte RN
    J Immunotoxicol; 2010 Mar; 7(1):27-38. PubMed ID: 20001788
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CD8+ T cells are crucial for the ability of congenic normal mice to reject highly immunogenic sarcomas induced in nude mice with 3-methylcholanthrene.
    Boesen M; Svane IM; Engel AM; Rygaard J; Thomsen AR; Werdelin O
    Clin Exp Immunol; 2000 Aug; 121(2):210-5. PubMed ID: 10931133
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cell surface antigens of chemically induced sarcomas of the mouse. I. Murine leukemia virus-related antigens and alloantigens on cultured fibroblasts and sarcoma cells: description of a unique antigen on BALB/c Meth A sarcoma.
    DeLeo AB; Shiku H; Takahashi T; John M; Old LJ
    J Exp Med; 1977 Sep; 146(3):720-34. PubMed ID: 197192
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro detection of cell-mediated immunity to individual tumor-specific antigens of chemically induced BALB/c fibrosarcomas.
    Carbone G; Colombo MP; Sensi ML; Cernuschi A; Parmiani G
    Int J Cancer; 1983 Apr; 31(4):483-9. PubMed ID: 6832855
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MCA sarcomas induced in scid mice are more immunogenic than MCA sarcomas induced in congenic, immunocompetent mice.
    Engel AM; Svane IM; Rygaard J; Werdelin O
    Scand J Immunol; 1997 May; 45(5):463-70. PubMed ID: 9160088
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The roles of two peritoneal T-lymphocyte populations in the in vivo rejection of methylcolanthrene-induced sarcoma.
    Kadhim SA; Rees RC; Barrington-Leigh J
    Cell Immunol; 1985 Jan; 90(1):234-41. PubMed ID: 2578328
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibody response of mice to chemically induced tumors.
    Brown JP; Klitzman JM; Hellström I; Nowinski RC; Hellström KE
    Proc Natl Acad Sci U S A; 1978 Feb; 75(2):955-8. PubMed ID: 204940
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro demonstration of cryosurgical augmentation of tumor immunity.
    Faraci RP; Bagley DH; Marrone J; Beazley RM
    Surgery; 1975 Mar; 77(3):433-8. PubMed ID: 1124499
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Specific desensitization of resistance against a syngeneic methylcholanthrene-induced sarcoma in C3Hf mice.
    Vaage J
    Cancer Res; 1972 Feb; 32(2):193-9. PubMed ID: 5058179
    [No Abstract]   [Full Text] [Related]  

  • 16. Specificity of in vivo tumor rejection assessed by mixing immune spleen cells with target and unrelated tumor cells.
    Röllinghoff M; Warner NL
    Proc Soc Exp Biol Med; 1973 Dec; 144(3):813-8. PubMed ID: 4543620
    [No Abstract]   [Full Text] [Related]  

  • 17. Immune selection in murine tumors. A study of MCA induced sarcomas in normal and immunodeficient mice.
    Engel AM; Svane IM; Rygaard J; Werdelin O
    Folia Microbiol (Praha); 1998; 43(5):483-6. PubMed ID: 9821304
    [No Abstract]   [Full Text] [Related]  

  • 18. Mechanism of the A/Ph.MC.S1 tumor graft rejection in syngeneic mice.
    Zákány J; Jánossy T; Németh P; Chihara G; Fachet J; Petri G
    Gan; 1983 Oct; 74(5):712-22. PubMed ID: 6357932
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Failure of immunogenic tumors to elicit cytolytic T cells in syngeneic hosts.
    Nelson DS; Hopper KE; Blanden RV; Gardner ID; Kearney R
    Cancer Lett; 1978 Aug; 5(2):61-7. PubMed ID: 308390
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cell-mediated suppression of tumor immunity has a non-specific component. II. Evidence from cell culture experiments.
    Hellström I; Hellström KE
    Int J Cancer; 1981; 27(4):487-91. PubMed ID: 6168592
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.